PharmaEssentia Corporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 977.73 million compared to TWD 86.76 million a year ago. Net loss was TWD 274.7 million compared to TWD 540.68 million a year ago. Basic loss per share from continuing operations was TWD 0.98 compared to TWD 2.08 a year ago.
For the six months, sales was TWD 1,229.47 million compared to TWD 184.44 million a year ago. Net loss was TWD 815.56 million compared to TWD 1,223.86 million a year ago. Basic loss per share from continuing operations was TWD 2.93 compared to TWD 4.71 a year ago.